Mississippi Advocate Pushed for Cancer Research Funding

Casey Rinewalt lobbied Mississippi's congressional delegation to support federal cancer research initiatives.

Updated on Oct. 7, 2026 in Cancer

Bold vector editorial illustration showing a single medical research vial on a sterile surface, representing cancer research progress. — Casey Rinewalt and fellow advocates lobbied Mississippi’s congressional delegation this week to secure increased federal funding for cancer research initiatives. AI Illustration. Upload story photo >

Live Poll

Should the federal government increase its annual spending on medical research?

Casey Rinewalt joined over 750 advocates in Washington, D.C., to urge Mississippi's lawmakers to increase federal funding for cancer research. The push coincides with support for the Clinical Trial Modernization Act.

Why it matters

Advocates seek to build on significant mortality reductions achieved through research to further improve patient outcomes. Increased funding remains a central goal for survivors and families following personal losses to the disease.

A 34% decline in cancer mortality rates has been observed over the last 30 years. More than 750 patients, survivors, and family members attended the national event to advocate for further research funding.

The players

Casey Rinewalt

She is a cancer advocate who lobbied federal representatives following the death of her mother.

American Cancer Society Cancer Action Network

This organization hosts the annual Leadership Summit and Lobby Day to coordinate advocacy efforts.

The details

Rinewalt met with members of Mississippi's congressional delegation and their staff to press for federal backing of cancer initiatives. The group is specifically advocating for the Clinical Trial Modernization Act, which aims to lower barriers to entry for low-income patients.

September 2026: The American Cancer Society Cancer Action Network held its annual Leadership Summit and Lobby Day.
November 2026: Midterm elections are scheduled to take place.

The Big Picture

This lobbying effort is centered on the Clinical Trial Modernization Act, which serves as a critical legislative benchmark for current cancer research policy. The initiative seeks to extend the success of past funding by addressing specific systemic barriers to medical trial participation.

The proposed Clinical Trial Modernization Act could lower financial and geographic barriers for low-income patients seeking access to experimental treatments. These legislative efforts aim to ensure that more individuals can participate in potentially life-saving clinical research.

The takeaway

Persistent advocacy remains a critical driver in securing federal resources that have historically lowered national cancer mortality. Readers can support these efforts by staying informed on pending legislation that impacts patient access to care.